SOBR.NASDAQSobr Safe, INC

DEF 14A: SOBR Safe Seeks Stockholder Approval for Share Issuance Related to Warrant Exercise

Sentiment:

Proxy Statement


SOBR Safe, Inc. is holding a special meeting of stockholders to approve the issuance of shares related to the exercise of a common stock purchase warrant, as required by Nasdaq rules.

Capital raiseThe company issued a new Common Stock Purchase Warrant to purchase 20,638,326 shares of the company's common stock at an exercise price of $0.27.The warrant was issued in exchange for the exercise of existing warrants.The company is seeking stockholder approval to allow the warrant holder to exercise the new warrant.

Summary

  • SOBR Safe, Inc. is convening a special meeting of stockholders on July 22, 2024, to vote on two proposals.
  • The first proposal seeks approval for the issuance of up to 20,638,326 shares of common stock upon the exercise of a Common Stock Purchase Warrant dated June 4, 2024, to comply with Nasdaq rules.
  • The second proposal concerns the adjournment of the Special Meeting to solicit additional proxies if there are insufficient votes to approve the first proposal or establish a quorum.
  • The record date for determining stockholders eligible to vote at the Special Meeting is June 18, 2024.
  • The Board of Directors recommends voting for both proposals.

Sentiment

Score: 6

Explanation: The document is a standard proxy statement, which is neutral in tone. The need for shareholder approval suggests potential financial constraints, but the warrant exercise could provide needed capital.

Positives

  • Approval of the share issuance would allow the company to receive $0.27 per share from the warrant holder.
  • The company is taking steps to comply with Nasdaq rules.

Negatives

  • If the share issuance is approved, existing stockholders will experience dilution of their economic and voting interests.
  • If the share issuance is not approved, the company will be required to hold additional special meetings every 60 days until approval is obtained or the warrant is no longer outstanding, incurring additional costs.

Risks

  • Failure to obtain stockholder approval for the share issuance will prevent the warrant holder from exercising the warrant.
  • The company may incur additional costs associated with holding repeated special stockholder meetings if the initial proposal fails.
  • Existing stockholders face potential dilution if the share issuance is approved.

Future Outlook

The company intends to hold special meetings every 60 days until stockholder approval is obtained for the share issuance or the warrant is no longer outstanding.

Management Comments

  • The Board of Directors recommends that the stockholders vote for the approval of the share issuance.
  • The Board of Directors recommends that the stockholders vote for the approval of the adjournment of the Special Meeting.

Industry Context

This type of request for shareholder approval for share issuance is common for companies listed on the Nasdaq Capital Market when issuing a significant number of shares at a price below market value, as it triggers the Nasdaq 20% Rule.

Comparison to Industry Standards

  • The Nasdaq 20% Rule is a standard requirement for companies listed on the Nasdaq Capital Market.
  • Many companies in similar situations, such as micro-cap and small-cap companies, have had to seek shareholder approval for similar share issuances to comply with Nasdaq regulations.
  • The process of issuing warrants and seeking shareholder approval is a common practice for raising capital, especially for companies with limited access to traditional financing.

Stakeholder Impact

  • Existing stockholders may experience dilution if the share issuance is approved.
  • The company's ability to raise capital could be affected if the share issuance is not approved.

Next Steps

  • Stockholders need to vote on the proposals before the Special Meeting on July 22, 2024.
  • The company will hold the Special Meeting and count the votes.
  • If Proposal 1 is not approved, the company will need to call another special meeting within 60 days.

Key Dates

DateDescription
September 27, 2021Initial exercise date of Amended and Restated Common Stock Purchase Warrants
March 30, 2022Initial exercise date of Amended and Restated Common Stock Purchase Warrants
September 30, 2022Date of Amended and Restated Common Stock Purchase Warrants
December 31, 2023End of the year for Form 10-K filing reference
June 4, 2024Date of the Common Stock Purchase Warrant and Inducement Letter.
June 18, 2024Record date for determining stockholders entitled to vote at the Special Meeting.
June 24, 2024Date of the Proxy Statement.
June 25, 2024Approximate date proxy materials were first made available to stockholders.
July 22, 2024Date of the Special Meeting of Stockholders.
March 5, 2025Deadline for stockholder proposals for the 2025 Annual Meeting of Stockholders.

Keywords

proxy statement, special meeting, stockholders, share issuance, warrant, Nasdaq, SOBR Safe

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.